Fox Chase patients may be eligible to receive third COVID-19 vaccine dose – Read More

MENU

Fox Chase Cancer Center Presentations at the Virtual American Urological Association 2021 Annual Meeting

September 9, 2021

PHILADELPHIA (September 9, 2021)—As thousands of urologists from around the world gather virtually for the American Urological Association 2021 Annual Meeting, 10 Fox Chase Cancer Center faculty and students will present their research on a range of topics.

Friday, September 10

Elizabeth Handorf, PhD; Alexander Kutikov, MD, FACS; Robert Uzzo, MD, MBA, FACS; Marc Smaldone, MD, MSHP, FACS; Andres Correa, MD

7:10 – 7:20 AM PDT
Podium Presentation
PD03-02: Racial disparities in prostate cancer treatment in a multi-institutional regional collaborative

Elizabeth Handorf, PhD; David YT Chen, MD, FACS; Andres Correa, MD; Richard Greenberg, MD, FACS; Marc Smaldone, MD, MSHP, FACS; Rosalia Viterbo, MD, FACS; Robert Uzzo, MD, MBA, FACS; Alexander Kutikov, MD, FACS

10:30 AM – 10:40 AM PDT
Podium Presentation
PD09-07: Insights into Short-term Postoperative Recovery after Transurethral Resection of Bladder Tumor: Harnessing Data from a Real-time Symptom Assessment Platform

Kevin Ginsburg, MD; Elizabeth Handorf, PhD; Jared Schober, MD; David YT Chen, MD, FACS; Richard Greenberg, MD, FACS; Rosalia Viterbo, MD, FACS; Robert Uzzo, MD, MBA, FACS; Alexander Kutikov, MD, FACS; Marc Smaldone, MD, MSHP, FACS; Andres Correa, MD

10:40 AM – 10:50 AM PDT
Podium Presentation
PD07-08: Association of Tumor Size and Surgical Approach with Oncological Outcomes in Patients with Adrenocortical Carcinoma


 

Saturday, September 11, 2021

Kevin Ginsburg, MD; Rosalia Viterbo, MD, FACS; Richard Greenberg, MD, FACS; Robert Uzzo, MD, MBA, FACS; David YT Chen, MD, FACS; Marc Smaldone, MD, MSHP, FACS; Alexander Kutikov, MD, FACS; Andres Correa, MD

7:00 AM – 8:15 AM PDT
Poster Session
MP19-16: Understanding the Risks of Surgery in Urologic Patients with Low Risk Cancers: Quantifying Perioperative Cardiopulmonary Events Following Minimally Invasive Prostatectomy and Partial Nephrectomy

Robert G. Uzzo, MD, MBA, FACS;  Phillip Abbosh, MD

10:30 AM – 11:45 AM PDT
Poster Session
MP26-02: Role of Anterior Prostate Sampling Using a Novel Philadelphia Hybrid Anatomic Transperineal (PHAT) Template: A single center experience

Kevin Ginsburg, MD; Rosalia Viterbo, MD, FACS; Richard Greenberg, MD, FACS; Robert Uzzo, MD, MBA, FACS; David YT Chen, MD, FACS; Marc Smaldone, MD, MSHP, FACS; Alexander Kutikov, MD, FACS; Andres Correa, MD

2:10 PM – 2:20 PM PDT
Podium Presentation
PD28-08: Sagacity of Same Day Discharge: Incidence and Timing of Postoperative Adverse Events Following Minimally Invasive Urologic Surgery

Andres Correa, MD; Rosalia Viterbo, MD, FACS; Richard Greenberg, MD, FACS; David YT Chen, MD; FACS Marc Smaldone, MD, MSHP, FACS; Robert Uzzo, MD, MBA, FACS; Alexander Kutikov, MD, FACS

1:40 PM – 1:50 PM PDT
Podium Presentation
PD28-05: Harnessing Choice Architecture in Urologic Practice: Implementation of an Opioid-Sparing Protocol Grounded in Behavioral Theory

 

 

Monday, September 13

Kevin Ginsburg, MD; Elizabeth Handorf, PhD; Laura Bukavina; David YT Chen, MD, FACS; Richard Greenberg, MD, FACS; Rosalia Viterbo, MD, FACS; Robert Uzzo, MD, MBA, FACS; Alexander Kutikov, MD, FACS; Marc Smaldone, MD, MSHP, FACS; Andres Correa, MD

2:40 PM – 2:50 PM PDT
Podium Presentation
PD63-11: Oncological Outcomes of cT1 Micropapillary Bladder Cancer Compared with cT2 Conventional Urothelial Carcinoma Treated with Radical Cystectomy

Kevin Ginsburg, MD; Elizabeth Handorf, PhD; Marc Smaldone, MD, MSHP, FACS

8:50 – 9:00 AM PDT
Podium Presentation
PD56-12: Utilization of MRI and Genomic Tests in Men with Low-Risk Prostate Cancer and a Limited Life Expectancy within a Multi-Institutional Regional Collaborative

Andres Correa, MD

7:00 – 8:15 AM PDT
Poster Session
MP58-02: Naming the Problem: Publishing Trends on Race, Health Disparities and Structural Racism

The Hospital of Fox Chase Cancer Center and its affiliates (collectively “Fox Chase Cancer Center”), a member of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence five consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

 

For more information, call 888-369-2427

Connect with Fox Chase